Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortium.

Autor: Rup, B.1, Pallardy, M.2, Sikkema, D.3, Albert, T.4, Allez, M.5, Broet, P.6, Carini, C.7, Creeke, P.8, Davidson, J.9, De Vries, N.10, Finco, D.11, Fogdell‐Hahn, A.12, Havrdova, E.13, Hincelin‐Mery, A.14, C. Holland, M.15, H. Jensen, P. E.16, Jury, E. C.17, Kirby, H.18, Kramer, D.19, Lacroix‐Desmazes, S.20
Zdroj: Clinical & Experimental Immunology. Sep2015, Vol. 181 Issue 3, p385-400. 16p. 2 Diagrams, 8 Charts.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje